Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Plans $0.09 Monthly Dividend

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) declared a monthly dividend on Thursday, April 30th. Shareholders of record on Friday, May 15th will be given a dividend of 0.0905 per share by the investment management company on Friday, May 29th. This represents a c) dividend on an annualized basis and a yield of 16.8%. The ex-dividend date is Friday, May 15th.

Neuberger Berman High Yield Strategies Fund Price Performance

NHS traded up $0.02 during mid-day trading on Friday, reaching $6.48. 18,342 shares of the stock were exchanged, compared to its average volume of 250,064. The company has a 50 day moving average price of $6.85 and a two-hundred day moving average price of $7.19. Neuberger Berman High Yield Strategies Fund has a 1 year low of $6.26 and a 1 year high of $7.80.

Hedge Funds Weigh In On Neuberger Berman High Yield Strategies Fund

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Mercer Global Advisors Inc. ADV purchased a new position in shares of Neuberger Berman High Yield Strategies Fund in the 3rd quarter worth about $80,000. Integrity Advisory Solutions LLC purchased a new position in shares of Neuberger Berman High Yield Strategies Fund in the 4th quarter worth about $81,000. CoreCap Advisors LLC purchased a new position in shares of Neuberger Berman High Yield Strategies Fund in the 3rd quarter worth about $94,000. XTX Topco Ltd purchased a new position in shares of Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth about $113,000. Finally, MRA Advisory Group boosted its holdings in shares of Neuberger Berman High Yield Strategies Fund by 10.9% in the 3rd quarter. MRA Advisory Group now owns 17,261 shares of the investment management company’s stock worth $129,000 after buying an additional 1,693 shares during the last quarter.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.